Modelling HIV/AIDS epidemic in Ukraine as a continuous-time Markov process
Bulletin of Taras Shevchenko National University of Kyiv. Series: Physics and Mathematics · 05.06.2026 · (1) · 27-33
DOI: 10.17721/1812-5409.2026/1.4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bulletin of Taras Shevchenko National University of Kyiv. Series: Physics and Mathematics, online erschienen am 05.06.2026. Verfasst von Olga Vasylyk und 1 weiteren Autor:innen. Die Arbeit nennt 13 Literaturangaben.
Abstract (Originalsprache)
Ukraine remains among the countries with the highest rates of HIV/AIDS spread globally. In this study, we fit a continuous-time Markov model to describe the progression of HIV to AIDS and ultimately to death for an individual and so obtain the means to model the epidemic on the global level. Our analysis reconstructs the information lost due left- and interval-censorship of empirical data. Our methodology integrates survival analysis, maximum likelihood estimation, Monte Carlo simulation, and the construction of confidence intervals. The results provide insights into the dynamics of the epidemic in Ukraine and can further be used in actuarial research of HIV/AIDS as an insurance risk.
Zitieren
APA
Vasylyk, O., & Okuniev, Y. (2026). Modelling HIV/AIDS epidemic in Ukraine as a continuous-time Markov process. Bulletin of Taras Shevchenko National University of Kyiv. Series: Physics and Mathematics, 27-33. https://doi.org/10.17721/1812-5409.2026/1.4
Vancouver
Vasylyk O, Okuniev Y. Modelling HIV/AIDS epidemic in Ukraine as a continuous-time Markov process. Bulletin of Taras Shevchenko National University of Kyiv. Series: Physics and Mathematics. 2026:27-33. doi:10.17721/1812-5409.2026/1.4
BibTeX
@article{Vasylyk2026,
author = {Vasylyk, Olga and Okuniev, Yehor},
title = {Modelling HIV/AIDS epidemic in Ukraine as a continuous-time Markov process},
journal = {Bulletin of Taras Shevchenko National University of Kyiv. Series: Physics and Mathematics},
year = {2026},
number = {1},
pages = {27--33},
doi = {10.17721/1812-5409.2026/1.4}
}
EUVIMED